MAPT and Alzheimer disease: A streptozotocin AD model reproducing themajor pathological processes in the brain (including the accumulation ofβ-amyloid and the hyperphosphorylated tau protein, as well as the spatialmemory abnormalities [30] that are alsotypical of AD patients) was used as a neurotoxic model [31].